• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/17

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

17 Cards in this Set

  • Front
  • Back
Heparin
MOA: cofactor for the activation of antithrombin, decr. thrombin & Xa; short t1/2
Uses: immediate anticoagulation for pulmonary embolism, stroke, acute coronary syndrome, MI, DVT; used during pregnancy (doesn't cross placenta); follow PTT
Toxicity: bleeding, thrombocytopenia (HIT), osteoporosis, drug-drug interactions; antidote-protamine sulfate
Lepirudin, bivalirudin (hirudin derivatives)
MOA: directly inhibits thrombin
Uses: alternative to heparin for anticoagulating patients w/ HIT
Warfarin/Coumadin
MOA: interferes w/ normal syn and gamma-carboxylation of vit K-dependent clotting factors II, VIII, IX, & X, and proteins C & S; metabolized by CYT-P450; long t1/2; follow PT
Uses: chronic anticoagulation; not used in pregnant woman (crosses placenta); follow PT/INR values
Toxicity: bleeding, teratogenic, skin/tissue necrosis, drug-drug interactions
Thrombolytics
Examples: streptokinase, urokinase, tPA, APSAC
MOA: directly or indirectly aid conversion of plaminogen to plasmin, which cleaves thrombin & fibrin clots; incr PT & PTT, no change in platelets
Uses: early MI, early ischemic stroke
Toxicity: bleeding; C/I in pats w/ active bleeding, hx of intracranial bleeding, recent sx, known bleeding diatheses, or severe HTN; antidote-aminocaproic acid
Aspirin (ASA)
MOA: acetylates & irreversibly inhibits COX-1 & COX-2 to prevent conversion of arachidonic acid to TxA2; incr bleeding time, no effect on PT, PTT
Uses: antipyretic, analgesic, anti-inflammatory, antiplatelet drug
Toxicity: gastric ulceration, bleeding, hyperventilation, Reye's syndrome, tinnitus
Clopidogrel, ticlopidine
MOA: inhibit platelet aggregation by irreversibly blocking ADP receptors; inhibit fibrinogen binding by preventing GPIIb:IIIa expression
Uses: acute coronary syndrome, coronary stenting; decr incidence or recurrence of thrombotic stroke
Toxicity: neutropenia (ticlopidine)
Abciximab
MOA: monoclonal Ab that binds to GPIIb:IIIa on activated platelets, preventing aggregation
Uses: acute coronary syndromes, percutaneous transluminal coronary angioplasty
Toxicity: bleeding, thrombocytopenia
Cancer drugs - cell cycle
inhibits M-phase
vinca alkaloids & toxols
Cancer drugs - cell cycle
inhibits S-phase
antimetabolites & etoposide
Cancer drugs - cell cycle
inhibits G2-phase
etoposide & bleomycin
Cisplatin, carboplatin
MOA: cross-link DNA
Uses: testicular, bladder, ovary, & lung carcinomas
Toxicity: nephrotoxicity & acoustic nerve damage
Hydroxyurea
MOA: inhibits ribonucleotide reductase -> decr DNA syn
Uses: melanoma, CML, sickle cell disease
Toxicity: bone marrow suppression, GI upset
Prednisone
MOA: may trigger apoptosis; may even work on nondividing cells
Uses: most commonly used glucocorticoid in cancer chemo; uses in CLL, Hodgkin's; also an immunosuppressant in autoimmune diseases
Toxicity: Cushing-like symptoms; immunosuppression, cataracts, acne, osteoporosis, HTN, peptic ulcers, hyperglycemia, psychosis
Tamoxifen, raloxifene
MOA: SERMs--receptor antagonists in breast and agonists in bone; block the binding of estrogen to estrogen receptor-positive cells
Uses: breast cancer; also useful to prevent osteoporosis
Toxicity: tamoxifen - may incr risk of endometrial carcinoma via partial agonist effects ("hot flashes"); raloxifene - no incr in endometrial carcinoma b/c it is an endometrial antagonist
Trastuzumab (Herceptin)
MOA: monoclonal Ab against HER-2 (erb-B2); helps kill breast cancer cells that overexpress HER-2, possibly through antibody-dependent cytotoxicity
Uses: metastatic breast cancer
Toxcity: cardiotoxicity
Imatinib (Gleevec)
MOA: philadelphia chromosome bcr-abl tyrosine kinase inhibitor
Uses: CML, GI stromal tumors
Toxicity: fluid retention
Rituximab
MOA: monoclonal Ab against CD20, found on most B-cell neoplasms
Uses: non-Hodgkin's lymphoma, rheumatoid arthritis